ALLO

Allogene Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

22.5%

Short % Float

9.2d to cover · High squeeze

87.3%

Inst % Float

10 holders · 2026-06-30

Blackrock Inc.

Top Holder

8.7% of float

269.6M sh

Public Float

37/100

Dilution Score

Medium

21 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

37/100

MEDIUM

Inst: 87.3% · Top: Blackrock Inc.

Biotech Analytics

Cell Therapy

29.0

Squeeze risk: HIGHBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk37

Clinical Trials38

Short Interest70